{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:28:18Z","timestamp":1792787298368,"version":"4.5.0"},"reference-count":51,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"unspecified","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000043","name":"American Association for Cancer Research","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100000043","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the College of Medicine\u2019s intramural grant Barton Pilot Award Program","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA234324"],"award-info":[{"award-number":["CA234324"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA134274"],"award-info":[{"award-number":["P30CA134274"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Development Enhancement Awards for Proposals (DEAP) from the UAMS Research Committee","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"a Seed of Science Award from the Winthrop P. Rockefeller Cancer Institute","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP2CA301099"],"award-info":[{"award-number":["DP2CA301099"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,4,28]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pancreatic ductal adenocarcinoma (PDAC), the most common malignant type of pancreatic cancer, is characterized by a dense desmoplastic stroma, low neoantigen burden, and a highly immunosuppressive tumor microenvironment (TME).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We present a novel strategy harnessing acute transplant rejection mechanisms by employing a recombinant oncolytic rVMG vector engineered to express murine alloantigens H-2Kb (rVMG-H-2Kb) or H-2Kk (rVMG-H-2Kk), thereby inducing tumor-specific antigenic mismatch responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In vitro, rVMG-H-2Kb and rVMG-H-2Kk exhibited strong replication and cytolytic activity while inducing cell surface expression of both H-2Kk and endogenous H-2Kb, in addition to upregulation of antigen presentation genes (\u03b22-microglobulin, Tap1, and Tapbp). In two immunocompetent PDAC models, intratumoral and systemic delivery of rVMG-H-2Kb and rVMG-H-2Kk delayed tumor progression, with rVMG-H-2Kk conferring a survival advantage. Multiplex immunohistochemistry and immunophenotyping revealed substantial TME remodeling, marked by increased effector T-cell infiltration, regulatory T-cell depletion, and reduced fibrosis. Spatial transcriptomics further showed compartment-specific immune activation and epithelial metabolic reprogramming, corroborating with enhanced tumor immunogenicity. Despite these effects, rVMG-H-2Kk also induced compensatory immunosuppressive pathways, including upregulation of antiviral response genes and immune checkpoint receptors such as programmed death-ligand-2. Importantly, combination therapy with rVMG-H-2Kk and murine checkpoint blockade (anti-programmed cell death protein-1 and anti-cytotoxic T-lymphocyte-associated protein 4) drastically improved survival compared to checkpoint blockade alone. Strikingly, surviving mice resisted tumor rechallenge, indicating the establishment of durable antitumor memory.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings establish rVMG-mediated alloantigen delivery as a novel immunotherapeutic platform capable of converting immune-cold tumors into immune-hot, sensitizing tumors to immune checkpoint inhibitors, and establishing durable antitumor immunity in PDAC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2025-013671","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:51:25Z","timestamp":1778601085000},"page":"e013671","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Pancreatic tumor microenvironment reprogramming via alloantigen-expressing virotherapy elicits tumor rejection and improves immunotherapy response"],"prefix":"10.1136","volume":"14","author":[{"given":"Mulu Z","family":"Tesfay","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Cios","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, University of Maryland Baltimore School of Medicine, Baltimore, Maryland, USA"},{"name":"Marlene and Stewart Greenebaum NCI Comprehensive Cancer Center, University of Maryland Baltimore School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9420-197X","authenticated-orcid":false,"given":"Zetao","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, University of Maryland Baltimore School of Medicine, Baltimore, Maryland, USA"},{"name":"Marlene and Stewart Greenebaum NCI Comprehensive Cancer Center, University of Maryland Baltimore School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khandoker U","family":"Ferdous","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, University of Maryland Baltimore School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randal S","family":"Shelton","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahaa","family":"Mustafa","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4130-1286","authenticated-orcid":false,"given":"Natalie M","family":"Elliott","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Mayo Clinic Arizona, Phoenix, Arizona, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A","family":"Raupach","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Mayo Clinic Arizona, Phoenix, Arizona, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila C","family":"Simoes","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle R","family":"Miousse","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Urbaniak","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Bauer","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric R","family":"Siegel","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R","family":"Post","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean C","family":"Chamcheu","sequence":"additional","affiliation":[{"name":"Department of Pathological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana, USA"},{"name":"Department of Biological Sciences and Chemistry, College of Sciences and Engineering, Southern University and A&M College, Baton Rouge, Louisiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rangaswamy","family":"Govindarajan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology\/Oncology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery Z","family":"Grdzelishvili","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of North Carolina at Charlotte, Charlotte, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J","family":"Cannon","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin E","family":"Fernandez-Zapico","sequence":"additional","affiliation":[{"name":"Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic Rochester, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei G","family":"Basnakian","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9585-5527","authenticated-orcid":false,"given":"Chiswili Yves","family":"Chabu","sequence":"additional","affiliation":[{"name":"Division of Biological Sciences, University of Missouri System, Columbia, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omeed","family":"Moaven","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, Louisiana State University Health Sciences Center New Orleans, New Orleans, Louisiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitesh J","family":"Borad","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Mayo Clinic Arizona, Phoenix, Arizona, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolni Marius","family":"Nagalo","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, University of Maryland Baltimore School of Medicine, Baltimore, Maryland, USA"},{"name":"Marlene and Stewart Greenebaum NCI Comprehensive Cancer Center, University of Maryland Baltimore School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"2026051208502064000_14.5.e013671.1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","article-title":"Therapeutic developments in pancreatic cancer","volume":"21","author":"Hu","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026051208502064000_14.5.e013671.2","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-020-00341-1","article-title":"Beyond just a tight fortress: contribution of stroma to epithelial-mesenchymal transition in pancreatic cancer","volume":"5","author":"Bulle","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"2026051208502064000_14.5.e013671.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2008.03.009"},{"key":"2026051208502064000_14.5.e013671.4","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12071596","article-title":"Enhancing Neoadjuvant Virotherapy\u2019s Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer","volume":"12","author":"Ferdous","year":"2024","journal-title":"Biomedicines"},{"key":"2026051208502064000_14.5.e013671.5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1258538"},{"key":"2026051208502064000_14.5.e013671.6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1287459","article-title":"Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target","volume":"15","author":"Hartupee","year":"2024","journal-title":"Front Immunol"},{"key":"2026051208502064000_14.5.e013671.7","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i46.7956"},{"key":"2026051208502064000_14.5.e013671.8","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.yexcr.2017.09.030","article-title":"CD25-expressing Th17 cells mediate CD8+ T cell suppression in CTLA-4 dependent mechanisms in pancreatic ductal adenocarcinoma","volume":"360","author":"Lang","year":"2017","journal-title":"Exp Cell Res"},{"key":"2026051208502064000_14.5.e013671.9","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-021-03205-3"},{"key":"2026051208502064000_14.5.e013671.10","doi-asserted-by":"crossref","DOI":"10.14309\/01.ajg.0001040020.64444.b7","article-title":"S2663\u2003Metastatic Pancreatic Adenocarcinoma: A Rare Case of Successful Checkpoint Inhibitor Monotherapy in High Tumor Mutational Burden With POLE Gene","volume":"119","author":"Perumal","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"2026051208502064000_14.5.e013671.11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.9636"},{"key":"2026051208502064000_14.5.e013671.12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaoncol.2022.0611","article-title":"Ipilimumab\/Nivolumab Therapy in Patients With Metastatic Pancreatic or Biliary Cancer With Homologous Recombination Deficiency Pathogenic Germline Variants","volume":"8","author":"Terrero","year":"2022","journal-title":"JAMA Oncol"},{"key":"2026051208502064000_14.5.e013671.13","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-017-0525-1"},{"key":"2026051208502064000_14.5.e013671.14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00582","article-title":"Allorecognition by T Lymphocytes and Allograft Rejection","volume":"7","author":"Marino","year":"2016","journal-title":"Front Immunol"},{"key":"2026051208502064000_14.5.e013671.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2016.02.001"},{"key":"2026051208502064000_14.5.e013671.16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41571-025-01006-0","article-title":"Using oncolytic viruses to induce hyperacute rejection against cancer","volume":"22","author":"Kaufman","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"2026051208502064000_14.5.e013671.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.12.010"},{"key":"2026051208502064000_14.5.e013671.18","doi-asserted-by":"crossref","DOI":"10.1016\/j.omton.2025.200937","article-title":"Resistance signatures to oncolytic vesiculoviruses in pancreatic ductal adenocarcinoma","volume":"33","author":"Watters","year":"2025","journal-title":"Mol Ther Oncol"},{"key":"2026051208502064000_14.5.e013671.19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.omto.2023.02.009","article-title":"Multi-modal efficacy of a chimeric vesiculovirus expressing the Morreton glycoprotein in sarcoma","volume":"29","author":"Watters","year":"2023","journal-title":"Mol Ther Oncolytics"},{"key":"2026051208502064000_14.5.e013671.20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-64053-0","article-title":"KPC-luciferase-expressing cells elicit an anti-tumor immune response in a mouse model of pancreatic cancer","volume":"14","author":"Ferrari","year":"2024","journal-title":"Sci Rep"},{"key":"2026051208502064000_14.5.e013671.21","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.3390\/cells11101701","article-title":"An In-Vitro Study of the Expansion and Transcriptomics of CD4+ and CD8+ Na\u00efve and Memory T Cells Stimulated by IL-2, IL-7 and IL-15","volume":"11","author":"Hopkins","year":"2022","journal-title":"Cells"},{"key":"2026051208502064000_14.5.e013671.22","article-title":"Tumor Lysis Syndrome in Solid Tumors: A Comprehensive Literature Review, New Insights, and Novel Strategies to Improve Outcomes","volume":"12","author":"Findakly","year":"2020","journal-title":"Cureus"},{"key":"2026051208502064000_14.5.e013671.23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/imm.13315","article-title":"Ubiquitin E3 ligase MID1 inhibits the innate immune response by ubiquitinating IRF3","volume":"163","author":"Chen","year":"2021","journal-title":"Immunology"},{"key":"2026051208502064000_14.5.e013671.24","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.23.13.4471-4484.2003"},{"key":"2026051208502064000_14.5.e013671.25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901750"},{"key":"2026051208502064000_14.5.e013671.26","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.immuni.2025.02.005","article-title":"IL-17RA signaling provides dual tumor-suppressor function during late-stage colorectal carcinogenesis","volume":"58","author":"Denk","year":"2025","journal-title":"Immunity"},{"key":"2026051208502064000_14.5.e013671.27","doi-asserted-by":"crossref","first-page":"216210","DOI":"10.1016\/j.canlet.2023.216210","article-title":"Acyl-CoA thioesterase 12 suppresses YAP-mediated hepatocarcinogenesis by limiting glycerolipid biosynthesis","volume":"565","author":"He","year":"2023","journal-title":"Cancer Lett"},{"key":"2026051208502064000_14.5.e013671.28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1408710","article-title":"Interleukin-17 directly stimulates tumor infiltrating Tregs to prevent cancer development","volume":"15","author":"Theune","year":"2024","journal-title":"Front Immunol"},{"key":"2026051208502064000_14.5.e013671.29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.omto.2020.09.012","article-title":"Upregulated CBX8 Promotes Cancer Metastasis via the WNK2\/MMP2 Pathway","volume":"19","author":"Jia","year":"2020","journal-title":"Molecular Therapy - Oncolytics"},{"key":"2026051208502064000_14.5.e013671.30","doi-asserted-by":"publisher","DOI":"10.4049\/immunohorizons.2400004"},{"key":"2026051208502064000_14.5.e013671.31","doi-asserted-by":"publisher","DOI":"10.1038\/nri3307"},{"key":"2026051208502064000_14.5.e013671.32","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01826-7"},{"key":"2026051208502064000_14.5.e013671.33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902593"},{"key":"2026051208502064000_14.5.e013671.34","doi-asserted-by":"publisher","DOI":"10.1038\/nri3156"},{"key":"2026051208502064000_14.5.e013671.35","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-024-00869-1","article-title":"High production of IL-12 by human dendritic cells stimulated with combinations of pattern-recognition receptor agonists","volume":"9","author":"Gilmour","year":"2024","journal-title":"NPJ Vaccines"},{"key":"2026051208502064000_14.5.e013671.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.10.026"},{"key":"2026051208502064000_14.5.e013671.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.03.018"},{"key":"2026051208502064000_14.5.e013671.38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.omto.2021.05.002","article-title":"Current strategies in engaging oncolytic viruses with antitumor immunity","volume":"22","author":"Boagni","year":"2021","journal-title":"Mol Ther Oncolytics"},{"key":"2026051208502064000_14.5.e013671.39","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3389\/fimmu.2019.01848","article-title":"Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study","volume":"10","author":"Marchini","year":"2019","journal-title":"Front Immunol"},{"key":"2026051208502064000_14.5.e013671.40","doi-asserted-by":"crossref","first-page":"561372","DOI":"10.3389\/fonc.2020.561372","article-title":"Remodeling of Tumor Immune Microenvironment by Oncolytic Viruses","volume":"10","author":"Zhang","year":"2020","journal-title":"Front Oncol"},{"key":"2026051208502064000_14.5.e013671.41","doi-asserted-by":"crossref","unstructured":"Pham TND , Shields MA , Spaulding C , et al . n.d. Preclinical Models of Pancreatic Ductal Adenocarcinoma and Their Utility in Immunotherapy Studies. Cancers (Basel) 13:440. doi:10.3390\/cancers13030440","DOI":"10.3390\/cancers13030440"},{"key":"2026051208502064000_14.5.e013671.42","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/jmv.25229","article-title":"Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5\/3-D24-GM-CSF) in peritoneal mesothelioma mouse model","volume":"90","author":"Kuryk","year":"2018","journal-title":"J Med Virol"},{"key":"2026051208502064000_14.5.e013671.43","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-55424-2","article-title":"Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms","volume":"16","author":"Sivakumar","year":"2025","journal-title":"Nat Commun"},{"key":"2026051208502064000_14.5.e013671.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.08.009"},{"key":"2026051208502064000_14.5.e013671.45","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00726-4"},{"key":"2026051208502064000_14.5.e013671.46","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-019-0703-0","article-title":"A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma","volume":"7","author":"Zhang","year":"2019","journal-title":"J Immunother Cancer"},{"key":"2026051208502064000_14.5.e013671.47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504030"},{"key":"2026051208502064000_14.5.e013671.48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1712126"},{"key":"2026051208502064000_14.5.e013671.49","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.4358"},{"key":"2026051208502064000_14.5.e013671.50","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00604-5"},{"key":"2026051208502064000_14.5.e013671.51","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd2712","article-title":"Revisiting the PD-1 pathway","volume":"6","author":"Patsoukis","year":"2020","journal-title":"Sci Adv"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2025-013671","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:51:33Z","timestamp":1778601093000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2025-013671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,12]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/jitc-2025-013671"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2025-013671","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.09.15.675641","asserted-by":"object"}]},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}